Matteo Pittacolo
Overview
Explore the profile of Matteo Pittacolo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sobhani N, Pittacolo M, DAngelo A, Marchegiani G
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002297
: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer, able to thrive in a challenging tumor microenvironment. Current standard therapies, including surgery, radiation, chemotherapy, and chemoradiation, have shown a dismal...
2.
Costantini A, Pittacolo M, Nezi G, Capovilla G, Costantini M, Vittori A, et al.
J Gastrointest Surg
. 2024 Dec;
29(2):101928.
PMID: 39674260
Background: There is no consensus on the definition of failure after treatment in patients with achalasia. The Eckardt score is used to define clinical outcomes. However, objective metrics are lacking....
3.
Vittori A, Capovilla G, Salvador R, Santangelo M, Provenzano L, Nicoletti L, et al.
J Gastrointest Surg
. 2024 Nov;
29(2):101888.
PMID: 39542415
Background: Most existing literature studies reported that laparoscopic fundoplication (LF) is safe in the setting of ineffective or weak peristalsis. However, the effect of the wrap on esophageal motility is...
4.
van Hootegem S, Pittacolo M, Lagarde S
JAMA Surg
. 2024 Oct;
159(12):1442.
PMID: 39382890
No abstract available.
5.
Sobhani N, DAngelo A, Pittacolo M, Mondani G, Generali D
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272947
The medical research field has been tremendously galvanized to improve the prediction of therapy efficacy by the revolution in artificial intelligence (AI). An earnest desire to find better ways to...
6.
Sobhani N, Neeli P, DAngelo A, Pittacolo M, Sirico M, Galli I, et al.
Int J Mol Sci
. 2021 Jun;
22(11).
PMID: 34073713
Metastatic prostate cancer is the most common cancer in males and the fifth cause of cancer mortality worldwide. Despite the major progress in this field, leading to the approval of...
7.
Roviello G, DAngelo A, Sirico M, Pittacolo M, Conter F, Sobhani N
Invest New Drugs
. 2021 Mar;
39(5):1456.
PMID: 33646490
No abstract available.
8.
Roviello G, DAngelo A, Sirico M, Pittacolo M, Conter F, Sobhani N
Invest New Drugs
. 2021 Jan;
39(3):879-890.
PMID: 33474634
Non-small cell lung cancer (NSCLC) is one of the most frequent causes of mortality in the western world. v-raf murine sarcoma viral oncogene homolog B (BRAF) is a member of...
9.
Roviello G, DAngelo A, Generali D, Pittacolo M, Ganzinelli M, Iezzi G, et al.
Immunotherapy
. 2019 May;
11(9):759-768.
PMID: 31060469
Gastric cancer (GC) is the fifth most common malignancy and the third cause of cancer-related deaths worldwide. Currently, surgery and chemotherapy remain the main therapeutic options and the prognosis of...
10.
Sobhani N, DAngelo A, Pittacolo M, Roviello G, Miccoli A, Corona S, et al.
Cells
. 2019 Apr;
8(4).
PMID: 30959874
Breast Cancer (BC) is the second most common type of cancer worldwide and displays the highest cancer-related mortality among women worldwide. Targeted therapies have revolutionized the way BC has been...